Application of Huihan Shutai in the Treatment of Patients with Chronic Kidney Disease Complicated with Stress Injury
This article explores the clinical effects of Huihan Shutai medical biocolloid dispersant in the treatment of patients with chronic kidney disease and pressure injury. 61 patients with chronic kidney disease and pressure injury were randomly divided into control group (n=31) and experimental group (n=30). In the control group, the pressure injury wounds were gauze-wrapped after saline debridement. Sexual injury wounds were sprayed to Huihan Shutai medical biocolloid dispersant.The results showed that the experimental group patients with pressure injury wound improvement rate was higher than the control group (X2=4.73, p=0.03), the experimental group patients hospitalization time (t=2.11, p=0.04) and hospitalization expenses (t=2.11, p=0.04 The results were lower than the control group. There was no statistically significant difference between the experimental group and the liver and kidney function (except urea) at the time of admission. The patient's urea value at discharge was lower than that at admission (t=2.50, p<0.05).Conclusion: Huihan Shutai Medical Biocolloid Dispersant is effective and safe for treating wounds in patients with chronic kidney disease and pressure injury, reducing hospitalization time and hospitalization expenses.